Generic name: elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide
Used for: HIV
Cash price
$4,300+ for 30 tablets
Pharmacies pay about this for Genvoya; you’d pay more.
Free from the maker, if you qualify Advancing Access Patient Assistance Program/Medication Assistance Program (PAP/MAP). Or call 1-800-226-2056.
See if you qualifyNo generic is sold yet.
Details for each option
Savings card from Gilead Sciences
Or call 1-866-664-5327.
“Eligible patients could pay as little as $0 per month.”
From the maker’s offer on gilead.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.
There isn’t one. An authorized generic is Genvoya itself, from the same company, sold without the brand name, and usually for less. For now Genvoya is the only choice; its maker’s savings card can lower what you pay.
No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.
GENVOYA is a four-drug combination of elvitegravir (EVG), an HIV-1 integrase strand transfer inhibitor (INSTI), cobicistat (COBI), a CYP3A inhibitor, and emtricitabine (FTC) and tenofovir alafenamide (TAF), both HIV-1 nucleoside analog reverse transcriptase inhibitors (NRTIs), and is indicated as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 25 kg who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically-suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen for at least 6 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of GENVOYA.
Source: the FDA label for Genvoya (Gilead Sciences, Inc.), February 3, 2025. Full label on DailyMed
Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/genvoya/